70 LKB1 deficiency in T cells promotes the development of gastrointestinal polyposis.
http://science.sciencemag.org/content/361/6400/406
69 A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice.
http://stm.sciencemag.org/content/10/443/eaan4116
68 An ingestible bacterial-electronic system to monitor gastrointestinal health.
http://science.sciencemag.org/content/360/6391/915
67 Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.
http://science.sciencemag.org/content/359/6382/1376
66 C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions.
http://science.sciencemag.org/content/359/6380/1161
65 Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis.
http://stke.sciencemag.org/content/11/519/eaan3580
64 Targeting of p53- and PUMA-dependent apoptosis protects intestinal stem cells, but not cancer cells, against chemotherapy.
http://stm.sciencemag.org/content/10/427/eaam7610
63 Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism.
https://www.nature.com/articles/nature25437
62 Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria.
http://science.sciencemag.org/content/359/6375/592
61 Elevated d-2-hydroxyglutarate during colitis drives progression to colorectal cancer.
http://www.pnas.org/content/115/5/1057
|
